Everolimus and mTORC1 Signaling in Energy Balance after De Novo Kidney Transplantation.

被引:0
|
作者
Junge, G. [1 ]
Wang, Z. [1 ]
Schwende, H. [1 ]
Cornu-Artis, C. [1 ]
Witte, S. [1 ]
机构
[1] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
966
引用
收藏
页码:317 / 317
页数:1
相关论文
共 50 条
  • [21] De novo sarcoidosis after kidney transplantation
    Kisner, T.
    Pfister, R.
    Engels, M.
    Benzing, T.
    Michels, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (10) : 476 - 478
  • [22] De novo malignancies after kidney transplantation
    Hung, Yao-Min
    Chou, Kang-Ju
    Hung, Shlh-Yuan
    Chung, Hsiao-Min
    Chang, Jui-Chen
    UROLOGY, 2007, 69 (06) : 1041 - 1044
  • [23] De Novo Malignancies after Kidney Transplantation
    Al-Adra, David
    Al-Qaoud, Talal
    Fowler, Kevin
    Wong, Germaine
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 434 - 443
  • [24] Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
    Robitaille, Aaron M.
    Christen, Stefan
    Shimobayashi, Mitsugu
    Cornu, Marion
    Fava, Luca L.
    Moes, Suzette
    Prescianotto-Baschong, Cristina
    Sauer, Uwe
    Jenoe, Paul
    Hall, Michael N.
    SCIENCE, 2013, 339 (6125) : 1320 - 1323
  • [25] DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling
    Lai, Yerui
    Zhao, Anjiang
    Tan, Minghong
    Yang, Mengliu
    Lin, Yao
    Li, Shengbing
    Song, Jinlin
    Zheng, Hongting
    Zhu, Zhiming
    Liu, Dongfang
    Liu, Chaohong
    Li, Ling
    Yang, Gangyi
    EMBO REPORTS, 2020, 21 (02)
  • [26] Renal allograft survival in the de novo hemolytic uremic syndrome (HUS) after kidney transplantation.
    Raez, L
    Santos, E
    Angulo, J
    Restrepo, A
    Bymes, J
    BLOOD, 1998, 92 (10) : 35A - 35A
  • [27] MTORC1 SIGNALING IN INSULIN RESISTANCE RATS WITH CHRONIC KIDNEY DISEASE
    Zhang, Li
    Li, Jiao
    Xu, Zhuo
    Zhao, Yang
    Chen, Xiangmei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [28] Rheb/mTORC1 Signaling Promotes Kidney Fibroblast Activation and Fibrosis
    Jiang, Lei
    Xu, Lingling
    Mao, Junhua
    Li, Jianzhong
    Fang, Li
    Zhou, Yang
    Liu, Wei
    He, Weichun
    Zhao, Allan Zijian
    Yang, Junwei
    Dai, Chunsun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (07): : 1114 - 1126
  • [29] Protocolar Biopsies in Patients with Subclinical De Novo DSA in Kidney Transplantation.
    Bertrand, D.
    Jaureguy, M.
    Garrouste, C.
    Sayegh, J.
    Bouvier, N.
    Caillard, S.
    Lanfranco, L.
    Galinier, A.
    Francois, A.
    Hau, F.
    Etienne, I.
    Gatault, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 507 - 507
  • [30] De novo minimal change disease (mcd) following kidney transplantation.
    Ghuman, Nimrta
    Patel, Vedavati
    de Palma, John
    Datla, Arvind
    Nataraj, Swetha
    Ranga, K. Vinay
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A49 - A49